Clinical Trial

Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 26, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the efficacy of colistin compared with colistin plus fosfomycin against carbapenem-resistant Acinetobacter baumanii infection in Thailand. The main questions it aims to answer the following main questions: 1. Which group has better clinical response at end of treatment 2. Which group has better clinical response at 72 hours and micrological cure at 72 hours and at end of treatment
Trial Details
NCT Number NCT06570850
Lead Sponsor Chiang Mai University
Conditions Infection Due to Carbapenem Resistant Acinetobacter
Enrollment 188 participants
Start Date 2023-04-01
Primary Completion 2025-03 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2024-08-26